Latest News

At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance, oncologists and payers came together to discuss the role of collaboration and data sharing for the successful implementation of the Oncology Care Model.
Patients newly diagnosed with non–small cell lung cancer (NSCLC) that expresses the programmed death ligand-1 (PD-L1) protein now have a new treatment option: pembrolizumab (Keytruda).
What are some of the challenges that clinical practices will face as they implement the Medicare Oncology Care Model (OCM)? What are some of the strategies that have worked for practices using similar payment models? These were some of the questions discussed at the Payer Exchange Summit V.
Ralph McDade, PhD, Myriad RBM's president, explained earlier this year how the precision medicine approach, pioneered in oncology, was finding its way into the cardiovascular arena, and that it could ultimately lead to develop of a risk panel that would make the ELIXA trial simpler and less costly.
A year after its high-profile arrival in New Jersey, Horizon's OMNIA plan will give most enrollees premium increases of 5% to 6%—far less than the 25% average increase announced in a report from HHS.
At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance, held October 24-25, 2016, in Tyson’s Corner, Virginia, Bruce Gould, MD, presented an overview of how cancer care has improved over the years, what the challenges are, and how practices can adapt to payment reform.
The opportunities for telehealth to radically transform the healthcare system are enormous, but the foremost priority of these innovations must be the delivery of value, said Reed V. Tuckson, MD, FACP, at the National Committee for Quality Assurance Quality Talks conference in Washington, DC, on Monday.
Working under the assumption that the outcome of the presidential race is pretty set, Avik S. A. Roy and John E. McDonough, DrPH, MPA, pondered the potential health policy changes during a Hillary Clinton presidency with a Republican-controlled Congress.
Dr Marianne Fazen on Why Cancer Is a Major Concern for Employers
Employers face tough decisions about rising costs, high-quality care, coordination of benefits, and workplace accommodations when employees are diagnosed with cancer, but they will always want to support those employees as best they can, according to Marianne Fazen, PhD, president and CEO of the Texas Business Group on Health.
Dr Kashyap Patel Discusses Challenges of OCM Implementation
Adopting the Oncology Care Model (OCM) is a challenging task for oncology practices that have to redesign their practices, but the shift from volume-based to value-based care is the way of the future, said Kashyap Patel, MD, of the Carolina Blood & Cancer Center.
What we're reading, October 25, 2016: individuals with discontinued Obamacare plans will have a special enrollment period; Arizona governor orders limits on opioid prescriptions; and the FDA aims to speed up generic drug reviews.
Ben Sommers Discusses Fitbit Group Health's Focus
Fitbit Group Health focuses on four areas: corporate wellness, research, insurer programs, and health management, said Ben Sommers, MBA, vice president of North America Business Development at Fitbit Wellness.
Including a real-time decision support tool in the prior authorization process significantly reduced the cost of therapy for UnitedHealthcare, while complying with nationally accepted guidelines established by the National Comprehensive Cancer Network.
Healthfirst's Medicare Advantage members are largely low income, and actually poorer than its Medicaid members. In order to reach these members and foster trust, Healthfirst makes itself a part of the fabric of the community.

From the Journals

A new study by researchers at the Perelman School of Medicine at the University of Pennsylvania has identified a biomarker that can predict response to treatment with pembrolizumab in stage IV patients with melanoma.
Paired communication training involving patients and oncologists achieves patient-centered care in advanced cancer.
Patients with a history of cancer were more likely to suffer from obesity than the general population, according to new research studying the incidence of obesity in cancer survivors.
Brain cancer has replaced leukemia as the leading cause of cancer-related death in children and adolescents diagnosed with cancer.
Daniel F. Hayes, MD, FASCO, 2016-2017 president of the American Society of Clinical Oncology, shares his vision of how the recommendations of the Blue Ribbon Panel will impact cancer care.
Healthcare providers and health plans are evaluating different care models in the clinic to understand what works best with ensuring continuity of care and improving outcomes.
As we enter a time of extraordinary advances in cancer care, some of the optimism over these advances has been tem­pered by the growing realization of the challenges of delivering these cancer care solutions.
The importance of doctor-patient communication is well established. Focus groups conducted with patients and oncologists help unravel why gaps exists and how to customize strategies for improvement.
The National Cancer Institute's Division of Cancer Control and Population Sciences created the Healthcare Delivery Research Program in January 2015, recognizing the need for empirical evidence to address cancer care challenges.
Diabetes Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Managed Care Cast
Managed Care Cast
Healthcare 2020

NEW! Focus on 2020: What does the Future of Healthcare Hold?

Most Popular

Upcoming Partner Events
October 19-20, 2016
Scottsdale, AZ
October 18-19, 2016
Philadelphia, PA
October 18-19, 2016
Philadelphia, PA

AJMC Strategic Alliance